Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53

Biochemical Pharmacology

Volumn 85, Issue 8, 2013, Pages 1057-1065

  Morad, Samy A F ^a,d   Madigan, James P ^b,e   Levin, Jonathan C ^a   Abdelmageed, Noha ^a   Karimi, Ramin ^a   Rosenberg, Daniel W ^b   Kester, Mark ^c   Shanmugavelandy, Sriram S ^c   Cabot, Myles C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d South Valley University   (Egypt)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

C6 ceramide; Ceramide; Colorectal cancer; P glycoprotein; p53; Tamoxifen

Indexed keywords

BIRICODAR; CASPASE; CERAMIDE; CYCLOSPORIN A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; TAMOXIFEN; VERAPAMIL;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CERAMIDES; COLORECTAL NEOPLASMS; DRUG SYNERGISM; HUMANS; P-GLYCOPROTEIN; PIPERIDINES; PYRIDINES; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875214546     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.01.015     Document Type: Article

References (47)

1. P. Naik, J. Karrim, and D. Hanahan The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors Genes Dev 10 1996 2105 2116
2. C.Y. Wang, J.C. Cusack Jr., R. Liu, and A.S. Baldwin Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB Nat Med 5 1999 412 417
3. S.A. Morad, and M.C. Cabot Ceramide-orchestrated signalling in cancer cells Nat Rev Cancer 13 2013 51 65
4. R. Kolesnick, and Z. Fuks Radiation and ceramide-induced apoptosis Oncogene 22 2003 5897 5906
5. C.P. Reynolds, B.J. Maurer, and R.N. Kolesnick Ceramide synthesis and metabolism as a target for cancer therapy Cancer Lett 206 2004 169 180
6. A.G. Charles, T.Y. Han, Y.Y. Liu, N. Hansen, A.E. Giuliano, and M.C. Cabot Taxol-induced ceramide generation and apoptosis in human breast cancer cells Cancer Chemother Pharmacol 47 2001 444 450
7. B.J. Maurer, L. Melton, C. Billups, M.C. Cabot, and C.P. Reynolds Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl) retinamide and modulators of ceramide metabolism J Natl Cancer Inst 92 2000 1897 1909
8. A.H. Merrill Jr., E.M. Schmelz, D.L. Dillehay, S. Spiegel, J.A. Shayman, and J.J. Schroeder Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology Toxicol Appl Pharmacol 142 1997 208 225
9. Y.A. Hannun, C. Luberto, and K.M. Argraves Enzymes of sphingolipid metabolism: from modular to integrative signaling Biochemistry 40 2001 4893 4903
10. M. Cabot Ceramide glycosylation and chemotherapy resistance A. Futerman, Ceramide signaling 2002 TX: Landes Bioscience Georgetown 133 139
11. Y.H. Zeidan, R.W. Jenkins, J.B. Korman, X. Liu, L.M. Obeid, and J.S. Norris Molecular targeting of acid ceramidase: implications to cancer therapy Curr Drug Targets 9 2008 653 661
12. X. Liu, J.C. Cheng, L.S. Turner, S. Elojeimy, T.H. Beckham, and A. Bielawska Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy Expert Opin Ther Targets 13 2009 1449 1458
13. R.J. Bleicher, and M.C. Cabot Glucosylceramide synthase and apoptosis Biochim Biophys Acta 1585 2002 172 178
14. N.S. Radin Killing tumours by ceramide-induced apoptosis: a critique of available drugs Biochem J 371 2003 243 256
15. A. Senchenkov, D.A. Litvak, and M.C. Cabot Targeting ceramide metabolism-a strategy for overcoming drug resistance J Natl Cancer Inst 93 2001 347 357
16. Y. Lavie, H. Cao, A. Volner, A. Lucci, T.Y. Han, and V. Geffen Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells J Biol Chem 272 1997 1682 1687
17. M.A. Tran, C.D. Smith, M. Kester, and G.P. Robertson Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development Clin Cancer Res 14 2008 3571 3581
18. T.C. Stover, Y.S. Kim, T.L. Lowe, and M. Kester Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug Biomaterials 29 2008 359 369
19. D.K. Perry, J. Carton, A.K. Shah, F. Meredith, D.J. Uhlinger, and Y.A. Hannun Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis J Biol Chem 275 2000 9078 9084
20. J.V. Chapman, V. Gouaze-Andersson, M.C. Messner, M. Flowers, R. Karimi, and M. Kester Metabolism of short-chain ceramide by human cancer cells-implications for therapeutic approaches Biochem Pharmacol 80 2010 308 315
21. A. Abe, D. Wu, J.A. Shayman, and N.S. Radin Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C Eur J Biochem 210 1992 765 773
22. S.Y. Chan, A.L. Hilchie, M.G. Brown, R. Anderson, and D.W. Hoskin Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species Exp Mol Pathol 82 2007 1 11
23. B. Tan, D. Piwnica-Worms, and L. Ratner Multidrug resistance transporters and modulation Curr Opin Oncol 12 2000 450 458
24. G.A. Meijer, A.B. Schroeijers, M.J. Flens, S.G. Meuwissen, P. van der Valk, and J.P. Baak Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis J Clin Pathol 52 1999 450 454
25. S.A. Morad, C. Schmidt, B. Buchele, B. Schneider, M. Wenzler, and T. Syrovets (8R)-3beta,8-dihydroxypolypoda-13E,17E,21-triene induces cell cycle arrest and apoptosis in treatment-resistant prostate cancer cells J Nat Prod 74 2011 1731 1736
26. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 1959 911 917
27. S.A. Morad, J.C. Levin, S.S. Shanmugavelandy, M. Kester, G. Fabrias, and C. Bedia Ceramide-antiestrogen nanoliposomal combinations-novel impact of hormonal therapy in hormone-insensitive breast cancer Mol Cancer Ther 11 2012 2352 2361
28. U. Potocnik, M. Ravnik-Glavac, R. Golouh, and D. Glavac Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers J Med Genet 39 2002 340 346
29. R. Callaghan, and C.F. Higgins Interaction of tamoxifen with the multidrug resistance P-glycoprotein Br J Cancer 71 1995 294 299
30. F. Esposito, M. Tornincasa, A. Federico, G. Chiappetta, G.M. Pierantoni, and A. Fusco High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria Cell Death Dis 3 2012 e383
31. H.H. Hsu, S.F. Cheng, C.C. Wu, C.H. Chu, Y.J. Weng, and C.S. Lin Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner Chin J Physiol 49 2006 110 116
32. C. Habold, A. Poehlmann, K. Bajbouj, R. Hartig, K.S. Korkmaz, and A. Roessner Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis J Cell Mol Med 12 2008 607 621
33. J. Tan, L. Zhuang, H.S. Leong, N.G. Iyer, E.T. Liu, and Q. Yu Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells Cancer Res 65 2005 9012 9020
34. B.S. Zolnik, S.T. Stern, J.M. Kaiser, Y. Heakal, J.D. Clogston, and M. Kester Rapid distribution of liposomal short-chain ceramide in vitro and in vivo Drug Metab Dispos 36 2008 1709 1715
35. L.Z. Shen, Y.B. Hua, X.M. Yu, Q. Xu, T. Chen, and J.H. Wang Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo World J Gastroenterol 11 2005 1060 1064
36. T. Hotta, H. Tanimura, H. Yamaue, M. Iwahashi, M. Tani, and T. Tsunoda Tamoxifen circumvents the multidrug resistance in fresh human gastrointestinal cancer cells J Surg Res 66 1996 31 35
37. F. Leonessa, M. Jacobson, B. Boyle, J. Lippman, M. McGarvey, and R. Clarke Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies Cancer Res 54 1994 441 447
38. Y. Nakayama, H. Sakamoto, K. Satoh, and T. Yamamoto Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system Cancer Lett 161 2000 63 71
39. D.J. Lindner, and E.C. Borden Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro J Interferon Cytokine Res 17 1997 681 693
40. P. Lointier, D.M. Wildrick, and B.M. Boman Growth effects of tamoxifen on Lovo colon carcinoma cells and cultured cells from normal colonic mucosa Anticancer Res 12 1992 1523 1525
41. A.F. Nica, C.C. Tsao, J.C. Watt, T. Jiffar, S. Kurinna, and P. Jurasz Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK Cell Cycle 7 2008 3362 3370
42. S.J. Furlong, N.D. Ridgway, and D.W. Hoskin Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin Int J Oncol 32 2008 537 544
43. G. Gutierrez, C. Mendoza, L.F. Montano, and R. Lopez-Marure Ceramide induces early and late apoptosis in human papilloma virus+ cervical cancer cells by inhibiting reactive oxygen species decay, diminishing the intracellular concentration of glutathione and increasing nuclear factor-kappaB translocation Anticancer Drugs 18 2007 149 159
44. S. Takeda, S. Mitsutake, K. Tsuji, and Y. Igarashi Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes J Biochem 139 2006 255 262
45. T. Stover, and M. Kester Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells J Pharmacol Exp Ther 307 2003 468 475
46. T.C. Stover, A. Sharma, G.P. Robertson, and M. Kester Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma Clin Cancer Res 11 2005 3465 3474
47. X. Liu, L. Ryland, J. Yang, A. Liao, C. Aliaga, and R. Watts Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia Blood 116 2010 4192 4201